What are the anesthesia considerations for a patient with DiGeorge syndrome (22q11.2 deletion)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 21, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Anesthesia Considerations for DiGeorge Syndrome (22q11.2 Deletion)

Patients with DiGeorge syndrome require meticulous perioperative management focused on four critical domains: difficult airway management with smaller intubation equipment, calcium monitoring and supplementation, bleeding risk assessment, and seizure prevention. 1

Preoperative Assessment Priorities

Airway and Anatomical Concerns

  • Anticipate difficult intubation and have smaller-sized intubation equipment immediately available 1
  • Evaluate for palatal anomalies, velopharyngeal dysfunction, and craniofacial abnormalities that complicate airway management
  • Screen for obstructive sleep apnea, which is common and may affect postoperative respiratory management 2
  • Consider laryngeal anomalies and vascular rings that may be present 1

Metabolic and Endocrine Evaluation

Check preoperative calcium, parathyroid hormone, magnesium, and thyroid function 2. Hypocalcemia is a critical perioperative risk:

  • Asymptomatic hypocalcemia can precipitate life-threatening seizures or cardiac arrhythmias under surgical stress 2
  • Have calcium chloride infusion immediately available 3
  • Monitor for prolonged QT interval on preoperative ECG 2
  • Ensure thyroid function is optimized, as hypothyroidism affects nearly 1 in 4 adults 2

Cardiac Assessment

Approximately 60-80% have congenital heart disease 4:

  • Obtain detailed cardiac history and recent echocardiogram
  • Common lesions include tetralogy of Fallot, truncus arteriosus, interrupted aortic arch type B, and septal defects 4
  • Even without known CHD history, assess for aortic root dilation and cardiovascular risk factors 2
  • Reoperative sternotomies are particularly high-risk, with documented vascular injury and difficulty achieving hemostasis 3

Hematologic and Immunologic Considerations

  • Check platelet count and function due to increased bleeding risk 1
  • Review immunodeficiency status—80% of infants have diminished T cell numbers 1
  • Use irradiated, CMV-negative blood products if significant immunodeficiency is present 3
  • Consider prophylactic antibiotics given the 23% postoperative infection rate 3

Intraoperative Management

Monitoring

  • Continuous calcium monitoring capability
  • Standard ASA monitors with particular attention to QT interval
  • Prepare for potential hemodynamic instability

Medication Considerations

  • "Start low, go slow" approach to all medications 2
  • Lower seizure threshold requires careful selection of anesthetic agents 2
  • Avoid medications that prolong QT interval if baseline prolongation exists
  • Have calcium chloride infusion ready—2 patients in a large cohort required intraoperative calcium infusions 3

Airway Management

  • Use smaller endotracheal tubes than age-predicted
  • Have multiple sizes and backup airway equipment immediately available
  • Consider fiberoptic intubation if significant palatal or craniofacial abnormalities

Postoperative Management

Expected Complications

Based on a large cohort study of 136 cardiac procedures 3:

  • 35% required prolonged mechanical ventilation (>24 hours)
  • 18% needed prolonged inotropic support (>72 hours)
  • 23% developed infectious complications
  • 8 patients developed postoperative hypocalcemia requiring treatment

Monitoring Protocol

  • Monitor calcium levels every 6-12 hours for the first 48 hours 1, 2
  • Continue cardiac monitoring for arrhythmias
  • Maintain seizure precautions
  • Monitor oxygen saturation closely given respiratory complications 1
  • Watch for signs of infection given immunodeficiency

Calcium Management

  • Supplement calcium promptly if levels drop
  • Consider prophylactic calcium supplementation in high-risk patients
  • Monitor for hypocalcemia symptoms: irritability, fatigue, abnormal movements, or seizures 2

Critical Pitfalls to Avoid

  1. Assuming normal calcium levels without checking—hypocalcemia can be asymptomatic until catastrophic complications occur 2
  2. Using standard-sized intubation equipment—have smaller sizes ready before induction 1
  3. Underestimating bleeding risk during reoperations—5 patients required bypass before sternotomy in one series 3
  4. Using non-irradiated blood products in patients with significant immunodeficiency 3
  5. Rapid medication dosing—the lowered seizure threshold demands cautious titration 2

Special Considerations

Pregnancy and Childbearing Age

Targeted calcium monitoring is essential perioperatively in pregnant patients 2

Neurologic Vulnerability

  • Four-fold increased epilepsy risk 2
  • Seizures may be provoked by hypocalcemia, hypomagnesemia, fever, or medications 2
  • Consider prophylactic anticonvulsants for high-risk procedures, particularly with clozapine use 2

The notably high rate of postoperative complications in this population (prolonged ventilation, hemodynamic support needs, and infections) mandates ICU-level monitoring for all but the most minor procedures 3. Despite these challenges, the same cohort demonstrated zero in-hospital or 30-day mortality, indicating that with appropriate anticipatory management, excellent outcomes are achievable 3.

References

Related Questions

What cardiac defect is most commonly associated with DiGeorge (22q11.2 deletion) syndrome?
What annual laboratory tests should be ordered for a teenage patient with DiGeorge (22q11.2 deletion) syndrome?
In a patient with a large 22q11.2 deletion encompassing the FGFR3 gene, how does the clinical phenotype and management differ between FGFR3 deletion (haploinsufficiency) and a gain‑of‑function FGFR3 mutation?
As the mother, could I be a carrier of a 22q11.2 microdeletion given my attention‑deficit/hyperactivity disorder (ADHD), normal intelligence, no health problems, and a non‑vision‑impairing coloboma?
What is the management approach for DiGeorge syndrome?
Can a patient with a history of transient ischemic attack take a butalbital‑acetaminophen‑caffeine combination?
What is the starting dose of semaglutide (4.36 mg/mL) in insulin syringe units and milliliters?
Should an elderly patient with chronic congestive heart failure, hyperlipidemia, hypertension, and a hemoglobin A1c of 5.9% be started on any glucose‑lowering therapy?
What questions should I ask a patient receiving medication‑assisted treatment (MAT) for substance use disorder?
Does C-reactive protein (CRP) automatically increase after any type of surgery?
In a patient with orthostatic tachycardia (POTS) and elevated norepinephrine/metanephrine levels that predate the use of methylphenidate (Ritalin) and venlafaxine (Effexor), how should the medications be managed and what diagnostic work‑up is recommended?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.